SLInterpreter: An Exploratory and Iterative Human-AI Collaborative System for GNN-Based Synthetic Lethal Prediction
Related Experiment Video
Updated: Jun 12, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Abstract:
Synthetic Lethal (SL) relationships, though rare among the vast array of gene combinations, hold substantial promise for targeted cancer therapy. Despite advancements in AI model accuracy, there is still a significant need among domain experts for interpretive paths and mechanism explorations that align better with domain-specific knowledge, particularly due to the high costs of experimentation. To address this gap, we propose an iterative Human-AI collaborative framework with two key components: 1) Human-Engaged Knowledge Graph Refinement based on Metapath Strategies, which leverages insights from interpretive paths and domain expertise to refine the knowledge graph through metapath strategies with appropriate granularity. 2) Cross-Granularity SL Interpretation Enhancement and Mechanism Analysis, which aids experts in organizing and comparing predictions and interpretive paths across different granularities, uncovering new SL relationships, enhancing result interpretation, and elucidating potential mechanisms inferred by Graph Neural Network (GNN) models. These components cyclically optimize model predictions and mechanism explorations, enhancing expert involvement and intervention to build trust. Facilitated by SLInterpreter, this framework ensures that newly generated interpretive paths increasingly align with domain knowledge and adhere more closely to real-world biological principles through iterative Human-AI collaboration. We evaluate the framework's efficacy through a case study and expert interviews.
More Related Videos
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016